These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 5848621)

  • 1. [Action in vivo of some thiocarbanilides on the vaccinia virus and on experimental poliomyelitis].
    Nguyên Dat-Xuong ; Martin du Pan R; Gazave JM; Nguyên-Hoang Nam ; Hasle B
    Ann Inst Pasteur (Paris); 1965 Oct; 109(4):600-4. PubMed ID: 5848621
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral chemotherapy.
    Bauer DJ
    Mod Trends Med Virol; 1967; 1(0):49-76. PubMed ID: 4950642
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of ectodermal lesions in intravenous vaccinia infected mice as a method to investigate the antiviral activity of isatin beta-thiosemicarbazone derivative (TSK VI compound).
    Walter M; Kolarz B; Zgórniak-Nowosielska I
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):187-94. PubMed ID: 7305631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral substances. Thiosemicarbazones. Discussion.
    Ann N Y Acad Sci; 1965 Jul; 130(1):128-34. PubMed ID: 5216625
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
    Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
    Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
    Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action in vivo of dibatod on skin lesions produced by vaccinia virus].
    Rico S; García-Gancedo A
    Microbiol Esp; 1972; 25(3):165-74. PubMed ID: 4664778
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccinia complications and methisazone therapy.
    McLean DM
    Clin Infect Dis; 2006 Jun; 42(11):1653. PubMed ID: 16652327
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral therapeutic intervention in poliomyelitis-like syndrome.
    Arya SC
    Brain Dev; 1999 Dec; 21(8):567; author reply 568. PubMed ID: 10598062
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of chemical agents on the vaccinia virus].
    Alonso Puertas ML; Ronda Lain E; García Gancedo A; Gil Fernández C
    Laboratorio; 1965 Nov; 40(239):401-23. PubMed ID: 5856922
    [No Abstract]   [Full Text] [Related]  

  • 11. Smallpox and smallpox vaccination.
    Worthington MG; Ross JJ
    N Engl J Med; 2003 May; 348(19):1920-5; author reply 1920-5. PubMed ID: 12740967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Testing a virostatic agent in persons vaccinated with poliomyelitis viruses].
    Alexander M; Eggert E
    Zentralbl Bakteriol Orig; 1964 Jun; 193(1):40-7. PubMed ID: 5319065
    [No Abstract]   [Full Text] [Related]  

  • 13. Infectious diseases. Report concludes polio drugs are needed--after disease is eradicated.
    Couzin J
    Science; 2006 Mar; 311(5767):1539. PubMed ID: 16543427
    [No Abstract]   [Full Text] [Related]  

  • 14. Polio endgame. Wanted: drug for a disappearing disease.
    Enserink M
    Science; 2004 Mar; 303(5666):1971. PubMed ID: 15044783
    [No Abstract]   [Full Text] [Related]  

  • 15. Alanosine, a new antiviral and antitumour agent isolated from a Streptomyces.
    Murthy YK; Thiemann JE; Coronelli C; Sensi P
    Nature; 1966 Sep; 211(5054):1198-9. PubMed ID: 5970033
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice.
    Boyle JJ; Haff RF; Stewart RC
    Antimicrob Agents Chemother (Bethesda); 1966; 6():536-9. PubMed ID: 5985284
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effective antiviral treatment of chronic poliomyelitis in adults].
    Lobzin VS; Golovkin VI; Nemchenko NS
    Sov Med; 1981; (3):104-8. PubMed ID: 6166054
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of concomitant treatment by cortisone and N-ethylisatin beta-thiosemicarbazone on neurovaccinia virus infected mice.
    Lieberman M; Pollikoff R; Pascale AM
    Proc Soc Exp Biol Med; 1966 Jun; 122(2):484-9. PubMed ID: 5980557
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiviral action of carbonyl-conjugated pentaene macrolides].
    Shneĭder MA; Shtil'bans EB; Rachkovskaia LA; Poltorak VA
    Antibiotiki; 1983 May; 28(5):352-7. PubMed ID: 6309075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
    Lidbury BA; Ramshaw IA; Sambhi SK
    Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.